Amara Research Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.50 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2019
About Amara Research
Amara Research Private Limited (ARPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 June 2018 (Six years and eight months 1 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Sravani Suryadevara, Nagamani Chinthala, and Narendra Suryadevara serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73100TG2018PTC124915
-
Company No.
124915
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Jun 2018
-
Date of AGM
31 Dec 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Amara Research?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sravani Suryadevara
|
Director | 04-Jun-2018 | Current |
|
Nagamani Chinthala
|
Director | 04-Jun-2018 | Current |
|
Narendra Suryadevara
|
Director | 04-Jun-2018 | Current |
Financial Performance of Amara Research.
Amara Research Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Amara Research?
In 2019, Amara Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medexiq Labs Private LimitedSravani Suryadevara and Narendra Suryadevara are mutual person
-
Amara Labs Private LimitedSravani Suryadevara and Narendra Suryadevara are mutual person
-
Esteem Laboratories Private LimitedSravani Suryadevara is a mutual person
-
Amara Life Sciences Private Limited
Sravani Suryadevara and Narendra Suryadevara are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Amara Research?
Unlock and access historical data on people associated with Amara Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Amara Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amara Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.